Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke

Stroke

Volumn 27, Issue 9, 1996, Pages 1553-1557

  Kim, Jong S ^a,b,c   Yoon, Sung S ^a   Kim, Yang H ^b   Ryu, Jin S ^a  

^a University of Ulsan   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

cytokines; interleukins; stroke; transforming growth factors

Indexed keywords

INTERLEUKIN 6; PROTEIN S 100; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INJURY SCALE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; STROKE;

EID: 0029816909     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.9.1553     Document Type: Article

References (49)

1. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki K, Satoh M. Induction of interleukin-1β mRNA in rat brain after transient forebrain ischaemia. J Neurochem. 1992;58:390-392.
2. Liu T, McDonnell PC, Young PR, White RF, Siren AL, Hallenbeck JM, Barone FC, Feuerstein GZ. lIterleukin-1 expression in ischemic rat brain. Stroke. 1993;24:1746-1752.
3. Buttini M, Sauter A, Boddeke HWGM. Induction of interleukin-β mRNA after focal cerebral ischaemia in the rat. Mol Brain Res. 1994;23:126-134.
4. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. Tumor necrosis factor in ischemic neurons. Stroke. 1994;25:1481-1488.
5. Wang X, Yue T-L, Young PR, Barone FC, Feuerstein GZ. Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J Cereb Blood Flow Metab. 1995;15:166-171.
6. Liu T, Young PR, McDonnell PC, White RF, Barone FC, Feuerstein GZ. Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci Lett. 1993;164:125-128.
7. Kim JS, Gautam SC, Chopp M, Zaloga C, Jones ML, Ward PA, Welch KMA. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neuroimmunol. 1995;56:127-134.
8. Wang X, Yue T-L, Barone FC, Feuerstein GZ. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke. 1995;26:661-666.
9. Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, del Zoppo GJ. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke. 1994;25:202-211.
10. Wang X, Siren A-L, Liu Y, Barone FC, Feuerstein GZ. Upregulation of intercellular adhesion molecule 1 (ICAM-1) of brain microvascular endothelial cells in rat ischemic cortex. Mol Bruin Res. 1995; 26:61-68.
11. Wang X, Yue T-L, Young PR, Barone FC, Feuerstein GZ. Demonstration of increased endothelial leukocyte adhesion molecule1 mRNA expression in rat ischemic cortex. Stroke. 1995;26: 1665-1669.
12. Fassbender K, Rossel S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci. 1994; 122:135-139.
13. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol. 1995;37:800-804.
14. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke. 1995;26: 1393-1398.
15. Fassbender K, Möassner R, Motsch L, Kischka U, Grau A, Hennerici M. Circulating selectin and immunoglobulin type adhesion molecules in acute ischemic stroke. Stroke. 1995;26:1361-1364.
16. Kim JS, Chopp M, Chen H, Levine SR, Carey JL, Welch KMA. Adhesive glycoprotein CD 11a and CD 18 are upregulated in leukocytes from patients with cerebral ischemia. J Neurol Sci. 1995; 128:45-50.
17. Kim JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci. 1996;137:69-78.
18. Sindic CJM, Chalon MP, Cambiaso CL, Laterre EC, Masson PL. Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1982;45:1130-1135.
19. Persson L, Hårdemark H-G, Gustafsson J, Rundström G, Mendel-Hartvig I, Esscher T, Påhlman S. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke. 1987;18:911-918.
20. Aurell A, Rosengren LE, Karlsson B, Olsson J-E, Zborikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke. 1991;22:1254-1258.
21. Rosengren L, Blomstrand C, Ekholm S, Jensen C, Karlsson J-E, Nyberg L. Brain specific proteins in cerebrospinal fluid and serum after cerebral infarctions. Eur J Neural. 1995;2(suppl 2):47. Abstract.
22. Eriksson S-E, Edström G, Olsson J-E. Evaluation of the brain specific proteins S-100 and neuron-specific enolase compared with the β2 microglobulin in serum from patients with acute ischemic stroke. Eur J Neural. 1995;2(suppl 2):48. Abstract.
23. Finch CE, Laping NJ, Morgan TE, Nichols NR, Pasinetti GM. TGF-β1 is an organizer of responses to neurodegeneration. J Cell Biochem. 1993;53:314-322.
24. Miah K, Von Arbin M, Britton M, De Faire U, Helmers C, Maasing R. Prognosis in acute stroke with special reference to some cardiac factors. J Chronic Dis. 1983;36:279-288.
25. Pozzilli C, Lenzi GL, Argentino C, Bozzao L, Rasura M, Giubilei F, Fieschi C. Peripheral white blood cell count in cerebral ischemic infarction. Acta Neurol Scand. 1985;71:396-400.
26. Friedman PJ. Serum creatinine: an independent predictor of survival after stroke. J Intern Med. 1991;229:175-179.
27. D'Erasmo E, Celi FS, Acca M, Mazzuoli G. Relationship between platelet and white blood cell counts during the early phase of cerebral infarction. Stroke. 1991;22:283. Letter.
28. D'Erasmo E, Acca M, Celi FS, Mazzuoli G. Correlation between plasma fibrinogen levels and white blood cell count after cerebral infarction. Stroke. 1991;22:1089. Letter.
29. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB. Transforming growth factor beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987;84:5788-5792.
30. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today. 1989; 10:258-261.
31. Wahl SM. Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J Clin Immunol. 1992;12:61-74.
32. McClain C, Cohen D, Phillips R, Ott L, Young B. Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J Lab Clin Med. 1991;118:225-231.
33. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol. 1989;19:689-694.
34. Schobitz B, Holsboer F, Kikkert R, Sutanto W, De Kloet ER. Peripheral and central regulation of IL-6 gene expression in endotoxin-treated rats. Endocr Regul. 1992;26:103-109.
35. Rott O, Tontsch U, Fleisher B, Cash E. Interleukin-6 production in 'normal' and HTLV-1 tax-expressing brain specific endothelial cells. Eur J Immunol. 1993;23:1987-1991.
36. da Cunha A, Jefferson J, Jackson RW, Vitkovic L. Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex. J Neuroimmunol. 1993;42:71-86.
37. Morganti-Kossmann MC, Kossmann T, Brandes ME, Mergenhagen SE, Wahl SM. Autocrine and paracrine regulation of astrocyte function by transforming growth factor β. J Neuroimmunol. 1992; 39:163-174.
38. Morgan TE, Nichols NR, Pasinetti GM, Finch CE. TGF-β1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp Neurol. 1993;120:291-301.
39. Hirano T. The biology of interleukin-6. Chem Immunol. 1992;51: 153-180.
40. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1-78.
41. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 1994;83:113-118.
42. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. Cytokine production by human fetal microglia and astrocytes. J Immunol. 1993;150:2659-2667.
43. Ulich TR, Yin S, Guo K, Yi E, Remick D, del Castillo J. Intratracheal injection of endotoxin and cytokines: interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol. 1991; 138:1097-1101.
44. Ranges GE, Figari IS, Espevik T, Palladino MA Jr. Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α. J Exp Med. 1987; 166:991-998.
45. Espevik T, Figari IS, Ranges GE, Palladino MA Jr. Transforming growth factor β1 (TGF-β1) and recombinant human tumor necrosis factor α reciprocally regulate the generation of lymphokine activated killer cell activity: comparison between natural porcine platelet-derived TGF-β1 and recombinant human TGF-β1. J Immunol. 1988; 140:2312-2316.
46. Gamble JR, Vadas MA. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Nature. 1988; 242:97-99.
47. Gamble JR, Khew-Goodall Y, Vadas MA. Transforming growth factor β inhibits E-selectin expression on human endothelial cells. J Immunol. 1993;150:4494-4503.
48. Wenisch C, Parschalk B, Burgmann H, Looareesuwan S, Graninger W. Decreased serum levels of TGF-β in patients with acute Plasmodium falciparum malaria. J Clin Immunol. 1995;15:69-73.
49. Hårdemark H-G, Ericsson N, Kotwica Z, Rundström G, Mendel-Hartvig I, Olsson Y, Påhlman S, Persson L. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg. 1989;71:727-731.